Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Compass Therapeutics (CMPX) EPS (Basic): 2019-2024

Historic EPS (Basic) for Compass Therapeutics (CMPX) over the last 6 years, with Dec 2024 value amounting to -$0.36.

  • Compass Therapeutics' EPS (Basic) changed negligibly% to -$0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.45, marking a year-over-year decrease of 25.00%. This contributed to the annual value of -$0.36 for FY2024, which is 9.09% down from last year.
  • As of FY2024, Compass Therapeutics' EPS (Basic) stood at -$0.36, which was down 9.09% from -$0.33 recorded in FY2023.
  • Compass Therapeutics' EPS (Basic)'s 5-year high stood at -$0.01 during FY2020, with a 5-year trough of -$1.31 in FY2021.
  • Its 3-year average for EPS (Basic) is -$0.35, with a median of -$0.36 in 2024.
  • As far as peak fluctuations go, Compass Therapeutics' EPS (Basic) skyrocketed by 81.50% in 2020, and later slumped by 36.46% in 2021.
  • Yearly analysis of 5 years shows Compass Therapeutics' EPS (Basic) stood at -$0.01 in 2020, then spiked by 81.50% to -$0.96 in 2020, then slumped by 36.46% to -$1.31 in 2021, then spiked by 71.76% to -$0.37 in 2022, then rose by 10.81% to -$0.33 in 2023, then dropped by 9.09% to -$0.36 in 2024.